DrugPatentWatch Database Preview

Quinapril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for quinapril hydrochloride and what is the scope of quinapril hydrochloride freedom to operate?

Quinapril hydrochloride is the generic ingredient in two branded drugs marketed by Pfizer Pharms, Actavis Elizabeth, Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Lupin, Mylan, Prinston Inc, Sun Pharm Inds Ltd, Teva, and Yaopharma Co Ltd, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for quinapril hydrochloride. Nineteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for quinapril hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	12
NDAs:	14
Drug Master File Entries:	11
Suppliers / Packagers:	19
Bulk Api Vendors:	58
Clinical Trials:	26
Patent Applications:	2,319
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for quinapril hydrochloride
DailyMed Link:	quinapril hydrochloride at DailyMed

Pharmacology for quinapril hydrochloride

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Synonyms for quinapril hydrochloride

(3S-(2(R*(R*)),3R*))-2-(2-((1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)-1-OXOPROPYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID MONOHYDROCHLORIDE

(3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride

(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid Hydrochloride

(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride

(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride

(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride

(3S)-2-[(2S)-2-{[(2S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YL]AMINO}PROPANOYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE

(3S)-2-{(2S)-2-[(1S)-1-ethoxycarbonyl-3-phenylpropylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride

(3S)-2-{N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride

(S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride

(S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-

(S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride

(S)-2-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, 1-ethyl ester, monohydrochloride

(S)-2-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid 1-Ethyl Ester Hydrochloride

[3S-[2[R*(R*)], 3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, monohydrochloride

2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid

2-ylamino)propanoyl)-1,2,3,4-

3-isoquinolineacrboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3S-(2(R*(R*)),3R*))-

3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (3S-(2(R*(R*)),3R*))-

3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3S-(2(R*(R*)),3R*))

3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3S-(2(R*(R*)),3R*))-

3-isoquinolinecarboxylicacid,1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-p

33067B3N2M

586Q558

82586-55-8

AB07655

AB2000675

AC-1655

AC1L1HXI

Accupril

Accupril (TN)

Accuprin

Accupro

Accupron

Accuretic

Acequin

Acuitel

Acuprel

AKOS015888532

AN-14706

AS-14026

Asig

BC206223

C07340

C25H30N2O5.HCl

CAS-82586-55-8

CCG-39543

CHEBI:8714

CHEMBL1201011

CI 906

CI-906

CI-906 (CN-109452)

CI906

Conan

Continucor

CPD000499582

CS-2591

D00459

DSSTox_CID_1221

DSSTox_GSID_21221

DSSTox_RID_76019

DTXSID3021221

Ectren

Hemokvin

HMS1922C15

HSDB 7046

HY-B0477

IBBLRJGOOANPTQ-JKVLGAQCSA-N

Korec

Koretic

Lidaltrin

LS-85471

MCULE-2623123657

MFCD00889215

MLS001076683

MolPort-003-666-434

monohydrochloride,(3s-(2(r*(r*)),3r*))-henylpropyl)amino)-1-oxopropyl)

NC00722

NCGC00094997-01

NCGC00167962-06

NCGC00257944-01

NE45380

NSC-758222

NSC758222

PD 109452-2

PD-109,452-2

PD-109522

Pharmakon1600-01503076

Quinapril hydrochloride

Quinapril (hydrochloride)

Quinapril for peak identification, European Pharmacopoeia (EP) Reference Standard

Quinapril for system suitability, European Pharmacopoeia (EP) Reference Standard

QUINAPRIL HCL

Quinapril Hydrochloride ,(S)

Quinapril hydrochloride (Accupril)

Quinapril hydrochloride (JP17/USP)

Quinapril hydrochloride [USAN:USP]

Quinapril hydrochloride [USAN]

quinapril hydrochloride hydrochloride

Quinapril hydrochloride, >=98% (HPLC), solid

Quinapril hydrochloride, European Pharmacopoeia (EP) Reference Standard

Quinapril Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

Quinapril hydrochloride, United States Pharmacopeia (USP) Reference Standard

Quinapril hydrochloride;

Quinapril N-Oxide

Quinapril.HCl

Quinazil

s2581

SAM002589972

SC-17215

SCHEMBL41404

SMR000499582

SPECTRUM1503076

SR-01000765404

SR-01000765404-2

SW199393-2

tetrahydroisoquinoline-3-carboxylic

Tox21_111381

Tox21_111381_1

Tox21_200390

UNII-33067B3N2M

Tentative approvals for QUINAPRIL HYDROCHLORIDE

Applicant	Application No.	Strength	Dosage Form
		EQ 40MG BASE	TABLET;ORAL
		EQ 20MG BASE	TABLET;ORAL
		EQ 10MG BASE	TABLET;ORAL

US Patents and Regulatory Information for quinapril hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076694-001	Dec 23, 2004	AB	RX	No	No
Prinston Inc	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	205823-001	Sep 15, 2016	AB	RX	No	No
Aurobindo Pharma Ltd	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	202725-004	Apr 29, 2013	AB	RX	No	No
Apotex Inc	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076240-003	Jan 26, 2006		DISCN	No	No

Expired US Patents for quinapril hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-002	Nov 19, 1991
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-001	Nov 19, 1991
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-004	Nov 19, 1991
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-002	Nov 19, 1991